Skip to content
value.today

Posterity Health, Inc.

Total raised
$27 M
2 rounds on record
Latest round
$17 M
Jan 2025
First round on record
Jun 2022
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Posterity Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2025$17 MNo. 2$10 to $50 million

Posterity Health, Inc.: Raise no. 2, Jan 2025

Investors in this round

27 investors had bought by the notice of Jun 12, 2025: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $17 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Pamela Joy Pure · Executive Officer, Director · Chief Executive Officer
  • Gerald M. McCarthy, Jr. · Director
  • Kyle M. Maierhofer · Director
  • Maria Joy Toler · Director
  • Shawn Joy Ellis · Director
  • Thomas K. Hearn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Pamela Joy Pure, Chief Executive Officer. Newest notice filed Jun 12, 2025 (1 amendment). Read the notice at the SEC.

equitySEC
Jun 2022$10 MNo. 1$2 to $10 million

Posterity Health, Inc.: Raise no. 1, Jun 2022

Investors in this round

18 investors had bought by the notice of Nov 7, 2022: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Pamela Joy Pure · Executive Officer, Director · Chief Executive Officer
  • Barrett Edward Cowan · Director
  • Donald A Holzworth · Director
  • Dylan Lawrence Pure · Director
  • Gerald M. McCarthy Jr. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Pamela Joy Pure, Chief Executive Officer. Newest notice filed Nov 7, 2022 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Posterity Health, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2025).

    SEC Form D · Jun 2025

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jun 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Posterity Health, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Posterity Health, Inc.
NameRoleNamed in
Pamela Joy PureChief Executive OfficerJun 2025
Gerald M. McCarthy, Jr.DirectorJun 2025
Kyle M. MaierhoferDirectorJun 2025
Maria Joy TolerDirectorJun 2025
Pamela Joy PureChief Executive OfficerJun 2025
Shawn Joy EllisDirectorJun 2025
Thomas K. HearnDirectorJun 2025
Barrett Edward CowanDirectorJan 2025
Shawn Edward EllisDirectorJan 2025
Donald A HolzworthDirectorNov 2022
Dylan Lawrence PureDirectorNov 2022
Gerald M. McCarthy Jr.DirectorNov 2022